SOD1 inhibition enhances sorafenib efficacy in HBV‐related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS‐mediated cell deathJooyoung Lee, Sung‐Gyu Lee|Journal of Cellular and Molecular Medicine|2024Cited by 7